Rockefeller Capital Management
TBIO

Rockefeller Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Rockefeller Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,211
Closed -$33K – 3945
2021
Q2 		$33K Hold
1,211
– – ﹤0.01% 2266
2021
Q1 		$19K Buy
1,211
+690
+132% +$15.7K ﹤0.01% 2318
2020
Q4 		$9K Hold
521
– – ﹤0.01% 2289
2020
Q3 		$7K Hold
521
– – ﹤0.01% 2137
2020
Q2 		$9K Hold
521
– – ﹤0.01% 1941
2020
Q1 		$5K Hold
521
– – ﹤0.01% 1984
2019
Q4 		$4K Hold
521
– – ﹤0.01% 1849
2019
Q3 		$5K Buy
+521
New +$4.92K ﹤0.01% 1659

Rockefeller Capital Management's TBIO Position: Q3 2021 in Review

Rockefeller Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,211 shares — an estimated $33K sold.

Rockefeller Capital Management first reported a position in TBIO in Q3 2019 and held it in 8 quarters. The position peaked at $33K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Rockefeller Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,211 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $33K.
  • Rockefeller Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Rockefeller Capital Management's Translate Bio, Inc. Common Stock position peaked at $33K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.